Home/Companies/Coloplast A/S

Coloplast A/S (COLO-B.CO) : key figures and financial history

Historical revenue, net income, net margin and earnings per share of Coloplast A/S, year by year from 2010 to 2026. Market data, amounts in US dollars.

Sector
Health
Country / place
🇩🇰 Europe
Market cap
16,88 billion $
Price at 13/11/2026
508,00 DKK

Year-by-year financial history

Revenue, net income, net margin, earnings per share (EPS) and revenue growth. Amounts in USD.

YearRevenueNet incomeNet marginBPARevenue growth
20101,41 billion $183,28 M$13,0 %0,86 $n/d
20111,50 billion $268,21 M$17,9 %1,27 $+6,7 %
20121,63 billion $323,51 M$19,9 %1,53 $+8,4 %
20131,72 billion $399,74 M$23,3 %1,90 $+5,6 %
20141,83 billion $352,41 M$19,2 %1,67 $+6,8 %
20152,05 billion $132,56 M$6,5 %0,63 $+11,9 %
20162,16 billion $463,44 M$21,4 %2,19 $+5,6 %
20172,29 billion $559,87 M$24,4 %2,64 $+5,8 %
20182,43 billion $566,95 M$23,4 %2,67 $+5,9 %
20192,65 billion $571,07 M$21,6 %2,69 $+9,1 %
20202,73 billion $618,85 M$22,6 %2,91 $+3,4 %
20212,86 billion $711,45 M$24,8 %3,34 $+4,8 %
20223,33 billion $693,90 M$20,8 %3,27 $+16,2 %
20233,61 billion $705,25 M$19,5 %3,27 $+8,5 %
20243,99 billion $744,92 M$18,7 %3,31 $+10,3 %
20254,11 billion $536,13 M$13,0 %2,38 $+3,1 %
20264,27 billion $453,26 M$10,6 %2,01 $+3,8 %

Revenue and net income evolution

Graphical representation of annual amounts (in USD).

201020122014201620182020202220242026
RevenueNet income

Current ratios

Valuation and profitability; price ratios calculated based on the price of 13/11/2026.

P/E
24,13
PEG
-1,19
EV/EBITDA
17,28
ROE
22,6 %
Debt / EPS
1,40
Yield
4,05 %
Methodology. The amounts (turnover, net income) are expressed in US dollars, converted at the 15/11/2026 exchange rate; the share price is displayed in its trading currency; ratios are currency-neutral. Revenue growth is calculated from one year to the next based on published real values. No value is estimated: a missing data point is noted as "n/d" or is not displayed. This information does not constitute investment advice. Share price and market capitalization as of 13/11/2026.